Glycogen-Metabolism

Page 1

www.Examville.com Online practice tests, live classes, tutoring, study guides Q&A, premium content and more.


GLUCONEOGENESIS GLYCOGEN METABOLISM


GLUCONEOGENESIS synthesis of glucose from noncarbohydrate precursors during longer periods of starvation  a very important pathway since the brain depends on glucose as its primary fuel (120g of the 160g daily need for glucose) and RBCs use only glucose as fuel  amount of glucose in body fluids is 20g and the amount that can be derived from glycogen is 190g  major noncarbohydrate sources are lactate, amino acids, and glycerol 


 

 

noncarbohydrate sources need to be first converted to either pyruvate, oxaloacetate or dihydroxyacetone phosphate (DHAP) to be converted to glucose major site is the liver with small amount taking place in the kidneys gluconeogenesis in the liver and kidneys helps maintain the glucose demands of the brain and muscles by increasing blood glucose levels little occurs in the brain, skeletal muscle or heart muscle not a reversal of glycolysis


NONCARBOHYDRATE SOURCES 

Pyruvate is converted to glucose in the gluconeogenetic pathway

Lactate is formed by active skeletal muscle when glycolytic rate exceeds oxidative rate; becomes glucose by first converting it to pyruvate

Amino acids are derived from dietary proteins and internal protein breakdown during starvation; becomes glucose by converting them first to either pyruvate or oxaloacetate

Glycerol is derived from the hydrolysis of triacylglycerols (TAG) or triglycerides; becomes glucose by conversion first to dihydroxyacetone phosphate (DHAP)


IRREVERSIBLE STEPS of GLYCOLYSIS  Causes of most of the decrease in free energy in glycolysis  

Bypassed steps during gluconeogenesis Steps catalyzed by the enzymes Hexokinase (glucose + ATP  G-6-P + ADP)  Phosphofructokinase (F-6-P + ATP  F-1,6-BP + ADP)  Pyruvate kinase (PEP + ADP  Pyruvate + ATP) 


NEW STEPS in GLUCOSE FORMATION from PYRUVATE via GLUCONEOGENESIS 

PEP is formed from pyruvate by way of oxaloacetate Pyruvate carboxylase  

Pyruvate + CO2 + ATP + HOH ------------ oxaloacetate + ADP + Pi + 2H+ PEP carboxykinase Oxaloacetate + GTP ------------- PEP + GDP + CO2

F-6-P is formed from F-1,6-BP by hydrolysis of the phosphate ester at carbon 1, an exergonic hydrolysis Fructose-1,6-bisphosphatase  Fructose-1,6-bisphosphate + HOH -------------- fructose-6-phosphate + Pi

Glucose is formed by hydrolysis of G-6-P 

Glucose-6-phosphatase

Glucose-6-phosphate + HOH ------------- glucose + Pi


RECIPROCAL REGULATION OF GLYCOLYSIS & GLUCONEOGENESIS Glucose

F-2,6-BP +

GLUCONEOGENESIS F-2,6-BP

Fructose-6-phosphate

AMP +

-

ATP

Citrate H+

PFK

AMP

F-1,6-BPase

-

-

Citrate + Fructose-1,6-bisphosphate

-

Several steps

PEP F-1,6-BP + ATP

PK

-

Alanine

-

ADP

-

PEP carboxykinase Oxaloacetate

Pyruvate

AcetylCoA + Pyruvate carboxylase ADP -


GLYCOGEN Readily mobilized storage form of glucose  very large, branched polymer of glucose residues linked via α-1,4 (straight) and α1,6 glycosidic bonds  branching occurs for every 10th glucose residue of the open helical polymer  not as reduced as fatty acids are and consequently not as energy-rich  serves as buffer to maintain blood sugar levels  Released glucose from glycogen can provide energy anaerobically unlike fatty acids 


Two major sites of glycogen storage are the liver (10% by weight) and skeletal muscles (2% by weight)

In the liver, its synthesis and degradation are regulated to maintain normal blood glucose

in the muscles, its synthesis and degradation is intended to meet the energy needs of the muscle itself

present in the cytosol as granules (10-40nm)


GLYCOGENOLYSIS ď Ź

Consists of three steps 1. release of glucose-1-phosphate from from the nonreducing ends of glycogen (phosphorolysis) 2. remodeling of glycogen substrate to permit further degradation with a transferase and Îą-1,6 glucosidase 3. conversion of glucose-1-phosphate to glucose-6-phosphate for further metabolism


Fates of Glucose-6-Phosphate 

Initial substrate for glycolysis

Can be processed by the pentose phosphate pathway to NADPH and ribose derivatives

Can be converted to free glucose in the liver, intestine and kidneys for release into the blood stream


Glycogen Glycogen phosphorylase Glycogen n-1 Glucose-1-phosphate Phosphoglucomutase

Glucose-6-phosphate Muscle,Brain

Glycolysis

Glucose-6-phosphatase

PPP

Liver

Pyruvate Lactate

Glucose

CO2 + HOH

Blood for use by other tissues

Ribose + NADPH


GLYCOGENESIS 

Regulated by a complex system and requires a primer, glycogenin

Requires an activated form of glucose, the Uridine diphosphate glucose (UDPglucose) formed from UTP and glucose-1phosphate

UDP-glucose is added to the nonreducing end of glycogen using glycogen synthase, the key regulatory enzyme in glycogen synthesis

Glycogen is then remodeled for continued synthesis


GLYCOGEN BREAKDOWN & SYNTHESIS ARE RECIPROCALLY REGULATED

Glycogen breakdown

Glycogen synthesis

Epinephrine

Adenylate cyclase

Adenylate cyclase

ATP

Protein kinase A

Phosphorylase kinase

Phosphorylase kinase

Phosphorylase b

cAMP

Protein kinase A

Glycogen synthase a

Glycogen synthase b

Phosphorylase a

PINK – inactive

GREEN - active


GLYCOGEN STORAGE DISEASE TYPE

DEFECTIVE ENZYME

ORGAN AFFECTED

GLYCOGEN IN AFFECTED ORGAN

CLINICAL FEATURES

I (Von Gierke)

Glucose-6phosphatase

Liver & kidney

Increased amount; normal structure

Hepatomegaly, failure to thrive, hypoglycemia, ketosis, hyperuricemia, hyperlipidemia

II (Pompe dse)

α-1,4 glucosidase

All organs

Massive increase in amount; normal structure

Cardiorespiratory failure causes death usually before age 2

III (Cori dse)

Amylo-1,6glucosidase (debranching)

Muscle & liver

Increased amount; short outer branches

Like type 1 but milder

IV (Andersen dse)

Branching enzyme (α-1,4 & 1,6)

Liver & spleen

Normal amount; very long outer branches

Progressive cirrhosis of the liver; liver failure causes death before age 2

V (McArdle dse)

Phosphorylase

muscle

Moderately increased amount; normal structure

Limited ability to perform strenuous exercise because of painful muscle cramps. Otherwise patient is normal or well-developed.

VI (Hers dse)

Phosphorylase

liver

Increased amount

Like type 1 but milder

VII

Phosphofructokina se

muscle

Increased amount; normal structure

Like type V

VIII

Phosphorylase kinase

liver

Increased amount; normal structure

Mild liver enlargement. Mild hypoglycemia


It’s FREE to join. http://www.examville.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.